Companies /Basic Materials
Celanese Corp - Series A
NYSE: CE Chemicals
$49.81
▲ $1.87 (+3.90%) today
Markets open · 9:57am ET

Celanese (CE) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
71%
EPS beat rate
+6.58%
Avg. EPS surprise
Consecutive EPS beats
CE vs Market · 30-day return after each reportCES&P 500
−20%−10%0%+10%+13.1%+7.2%Q1 25+10.6%+2.3%Q2 25+4.8%+2.5%Q3 25+3.8%−5.5%Q4 25−21.0%+0.7%Q1 26+3.6%+0.1%Q2 26
−20%−10%0%+10%Q1 25Q3 25Q1 26
CE EPS Trend · estimate vs actualEstimateActual
$0.00$0.70$1.40$2.10$0.39$0.57Q1 25$1.40$1.44Q2 25$1.22$1.34Q3 25$0.91$0.67Q4 25$0.88$0.85Q1 26$2.22$2.45Q2 26$1.56$1.65Q3 26
$0.00$0.70$1.40$2.10Q1 25Q3 25Q1 26Q3 26
CE Revenue Trend · estimate vs actualEstimateActual
$0$800.0M$1.6B$2.4B$2.3B$2.4BQ1 25$2.5B$2.5BQ2 25$2.5B$2.4BQ3 25$2.2B$2.2BQ4 25$2.3B$2.3BQ1 26$2.8B$2.8BQ2 26$2.6B$2.6BQ3 26
$0$800.0M$1.6B$2.4BQ1 25Q3 25Q1 26Q3 26

How Often Does Celanese Beat Earnings Estimates?

Celanese beat EPS estimates in 5 of its last 7 reported quarters, and has beaten 2 quarters in a row.

CE quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Adjusted EPS excludes $109 million of Certain Items, including $87 million of exit and shutdown costs, $12 million of mergers, acquisitions and dispositions costs, and $10 million of legal settlements and commercial disputes. GAAP diluted EPS from continuing operations was $0.68. $1.65 est. $1.56 +5.57% $2.6B est. $2.6B −2.61%
Q2 2026 $2.45 est. $2.22 +10.21% $2.8B est. $2.8B −0.89%
Q1 2026 $0.85 est. $0.88 −3.61% $2.3B est. $2.3B −0.41%
Q4 2025 $0.67 est. $0.91 −26.37% $2.2B est. $2.2B −2.02%
Q3 2025 $1.34 est. $1.22 +9.59% $2.4B est. $2.5B −3.71%
Q2 2025 $1.44 est. $1.40 +2.82% $2.5B est. $2.5B +1.89%
Q1 2025 $0.57 est. $0.39 +47.82% $2.4B est. $2.3B +5.54%

Figures from SEC filings and company reports. Not investment advice.